- A Study on the Serologic Parameters in Petients with Anemia of Chronic Renal Failure-According to Erythropoietin Treatment
-
Jong Sik Lim, Ho Jung Kang, Won Jong Park, Jun Young Do, Kyeung Woo Yun
-
Yeungnam Univ J Med. 1994;11(1):82-93. Published online June 30, 1994
-
DOI: https://doi.org/10.12701/yujm.1994.11.1.82
-
-
 Abstract
 PDF
- Clinical study was carried out on the 64 hemodialysis patients (HD) with chronic renal failure who had been treated from December 1992 to July 1993 in Yeungnam University Hospital. The following results were obtained. In hematologic parameters, MCH was 28.8±2.0 pg, and MCV was 92.4±4.7 fl. Result revealed normochromic and normocytic anemia. Mean values of serum ferritin were 657.4±292.0 ng/ml in men and 511.5±370 g in women. Mean values of serum iron were 145.5±63.7 µg/dl. Mean values of transferrin saturation was 61.6±28.4%. Serum ferritin, serum iron and transferrin saturation were higher in HD group than normal reference. In erythropoietin treatment group, Hb and Hct were significantly higher than non-erythropoietin treatment group. Amount of transfusion was significantly higher in non-erythropoietin treatment group than erythropoietin treatment group (p<0.05). Values of iron, transferrin saturation were significantly higher in abnormal liver function test (LFT0 hemodialysis group than normal LFT group (p<0.05). Transfusion amounts revealed positive correlation with ferritin (r=0.4675), transferrin saturation (r=0.3823) and iron (r=0.3386) (p<0.05). In conclusion, erythropoietin treatment can reduce requirement of blood transfusion and transfusion related side effects such as iron overload, hemosiderosis and hemochromatosis.
- A case of SIADH in small cell lung cancer.
-
Kyu Chang Won, Jong Sik Lim, Chan Woo Lee, Hyoung Woo Lee, Choong Ki Lee, Jin Hong Chung, Myoung Soo Hyun, Bong Sup Shim, Hyun Woo Lee
-
Yeungnam Univ J Med. 1991;8(2):227-234. Published online December 31, 1991
-
DOI: https://doi.org/10.12701/yujm.1991.8.2.227
-
-
Abstract
PDF
- The syndrome of inappropriate ADH secretion is a disorder characterized by hyponatremia which results from water retention attributable to ADH release. The hallmark of SIADH is hyponatremia due to water retention, in the presence of urinary osmolality above plasma osmolality. The SIADH was initially described by Schwartz et al (1957). This syndrome, first recognized in patients with bronchogenic carcinoma, has now been observed in a variety of other illnesses. Recently, we encountered a 59 year-old female with small cell lung cancer, also she had SIADH. Thus, we present a case and review the literature on the subject.
|
E-Submission
Yeungnam University College of Medicine
